Literature DB >> 15834942

Cytogenetic alterations in nonmelanoma skin cancer: a review.

Kevin J Ashton1, Melanie A Carless, Lyn R Griffiths.   

Abstract

Since the advent of cytogenetic analysis, knowledge about fundamental aspects of cancer biology has increased, allowing the processes of cancer development and progression to be more fully understood and appreciated. Classical cytogenetic analysis of solid tumors had been considered difficult, but new advances in culturing techniques and the addition of new cytogenetic technologies have enabled a more comprehensive analysis of chromosomal aberrations associated with solid tumors. Our purpose in this review is to discuss the cytogenetic findings on a number of nonmelanoma skin cancers, including squamous- and basal cell carcinomas, keratoacanthoma, squamous cell carcinoma in situ (Bowen's disease), and solar keratosis. Through classical cytogenetic techniques, as well as fluorescence-based techniques such as fluorescence in situ hybridization and comparative genomic hybridization, numerous chromosomal alterations have been identified. These aberrations may aid in further defining the stages and classifications of nonmelanoma skin cancer and also may implicate chromosomal regions involved in progression and metastatic potential. This information, along with the development of newer technologies (including laser capture microdissection and comparative genomic hybridization arrays) that allow for more refined analysis, will continue to increase our knowledge about the role of chromosomal events at all stages of cancer development and progression and, more specifically, about how they are associated with nonmelanoma skin cancer. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15834942     DOI: 10.1002/gcc.20183

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.

Authors:  Aleksandar Sekulic; Su Y Kim; Galen Hostetter; Stephanie Savage; Janine G Einspahr; Anil Prasad; Paul Sagerman; Clara Curiel-Lewandrowski; Robert Krouse; G Timothy Bowden; James Warneke; David S Alberts; Mark R Pittelkow; David DiCaudo; Brian J Nickoloff; Jeffrey M Trent; Michael Bittner
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-28

2.  Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes.

Authors:  Laurie G Hudson; James M Gale; R Steven Padilla; Gavin Pickett; Bryan E Alexander; Jing Wang; Donna F Kusewitt
Journal:  Mol Carcinog       Date:  2010-07       Impact factor: 4.784

3.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

4.  Deciphering squamous cell carcinoma using multidimensional genomic approaches.

Authors:  Ewan A Gibb; Katey S S Enfield; Ivy F L Tsui; Raj Chari; Stephen Lam; Carlos E Alvarez; Wan L Lam
Journal:  J Skin Cancer       Date:  2010-12-27

5.  GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis.

Authors:  E Pantazi; E Gemenetzidis; G Trigiante; G Warnes; L Shan; X Mao; M Ikram; M-T Teh; Y-J Lu; M P Philpott
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

6.  Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.

Authors:  Liesbeth Hameetman; Suzan Commandeur; Jan Nico Bouwes Bavinck; Hermina C Wisgerhof; Frank R de Gruijl; Rein Willemze; Leon Mullenders; Cornelis P Tensen; Harry Vrieling
Journal:  BMC Cancer       Date:  2013-02-05       Impact factor: 4.430

7.  PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.

Authors:  C A Harwood; N R Attard; P O'Donovan; P Chambers; C M Perrett; C M Proby; J M McGregor; P Karran
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

8.  The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma.

Authors:  P Koch; A Stenzinger; M Viard; D Märker; P Mayser; M Nilles; D Schreiner; K Steger; M Wimmer
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

Review 9.  Novel medical strategies combating nonmelanoma skin cancer.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

10.  NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis.

Authors:  Charlotte M Proby; Catherine A Harwood; Irene M Leigh; Andrew P South; Karin J Purdie; Stephen A Watt; Sam Haldenby; Nicoline den Breems; Michelle Dimon; Sarah T Arron; Michael J Kluk; Jon C Aster; Angela McHugh; Dylan J Xue; Jasbani Hs Dayal; Kim S Robinson; Sm Hasan Rizvi
Journal:  J Invest Dermatol       Date:  2014-03-24       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.